NasdaqCM - Delayed Quote USD

Aethlon Medical, Inc. (AEMD)

Compare
0.3750 +0.0050 (+1.35%)
At close: October 25 at 4:00 PM EDT
0.3767 +0.00 (+0.45%)
After hours: October 25 at 7:26 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. James B. Frakes M.B.A. CEO, CFO, Secretary & Director 416.45k -- 1957
Mr. Guy F. Cipriani BS (Eng.), MBA Senior VP & COO 378.06k -- 1971
Dr. Steven P. LaRosa M.D. Chief Medical Officer 430k -- 1968

Aethlon Medical, Inc.

11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
United States
619 941 0360 https://www.aethlonmedical.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
14

Description

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Corporate Governance

Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2024 at 9:15 PM UTC - November 18, 2024 at 9:15 PM UTC

Aethlon Medical, Inc. Earnings Date

Recent Events

October 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 19, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 15, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

August 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 27, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 24, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers